Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GlaxoSmithKline and XenoPort Respond to FDA on Horizant™ for RLS
GlaxoSmithKline and XenoPort Respond to FDA on Horizant™ for RLS
GlaxoSmithKline and XenoPort Respond to FDA on Horizant™ for RLS
Submitted by
admin
on November 6, 2010 - 12:57pm
Source:
Yahoo/BusinessWire
News Tags:
GSK
XenoPort
Horizant
restless legs syndrome
Headline:
GlaxoSmithKline and XenoPort Respond to FDA on Horizant™ for RLS
Do Not Allow Advertisers to Use My Personal information
